MHRA reminds prescribers of latest advice regarding adrenaline auto-injectors

In an effort to support safe use of adrenaline auto-injectors the MHRA has published a summary of all relevant alerts and letters issued to healthcare professionals in recent months.

Patients should continue to follow existing advice to carry two in-date pens with them at all times. | SCIENCE PHOTO LIBRARY
Patients should continue to follow existing advice to carry two in-date pens with them at all times. | SCIENCE PHOTO LIBRARY

The latest issue of the Drug Safety Update provides an overview of recent advice relating to Emerade, EpiPen and Jext, the three adrenaline auto-injector devices available in the UK.

The advice for healthcare professionals covers possible activation failure with Emerade pens, including what to tell patients and/or carers in possession of these devices. Images showing what the pen should look like before and after activation are included in a recent letter to patients.

The update reiterates that any suspected product quality defects should be reported to the Yellow Card Scheme. Devices that are thought to be non-activated or otherwise defective should be retained for investigation and the manufacturer contacted for advice.

The update also recaps the information sent to healthcare professionals regarding the extended use of specific batches of EpiPen and Jext beyond their labelled expiry dates, an action which was taken to support adequate supply of these products.

MHRA advice for patients applicable to the use of all three adrenaline auto-injectors was issued in August 2018 and remains valid.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Drug shortages - live tracker

Drug shortages - live tracker

Use our constantly updated shortages tracker to check...

Live updates: Coronavirus (COVID-19) in the UK

Live updates: Coronavirus (COVID-19) in the UK

Use our timeline to follow the latest coronavirus developments...

Consider bisphosphonates to combat osteoporosis risk in asthma patients taking steroids, say researchers
Medicines shortages increase as prescribing costs rise £158 million

Medicines shortages increase as prescribing costs rise £158 million

Increasing medicines shortages have added more than...